On March 18, 2007, CVS agreed to pay $36.7 million as a result of allegations that the company improperly switched patients from the tablet version of the prescription drug Zantak to a more expensive version in order to increase Medicaid reimbursement. The fraud was brought to light by a Bernard Listiza, a pharmacist in Washington, DC. Following extensive negotiations between the US Attorney”s Office and CVS, CVS agreed to pay $36.7 million for defrauding the government. The United States” share of the settlement was approximately $21.1 million, with 23 states and the District of Columbia sharing $15.6 million. More importantly, the pharmacist, Mr. Listiza, received $4,309,330.74 as his share of the settlement.

For further information on whistleblower lawsuits, click on the following links:

Whistleblower Protection

Leave a Reply

Your email address will not be published. Required fields are marked *